Coronary stent Promus PREMIER™

platinium-chromiumpolymerdrug eluting

Subtitle
Everolimus-Eluting Platinum Chromium Coronary Stent System

Overview
Features the first customized Platinum Chromium (PtCr) stent architecture combined with Everolimus drug elution and a PVDF‑HFP polymer. The system is designed for percutaneous coronary intervention and offers a range of nominal diameters and stent lengths to match lesion and vessel requirements.

Key benefits

• Customized PtCr stent architecture for targeted radial strength and deliverability
• Everolimus drug elution with PVDF‑HFP polymer for controlled antiproliferative therapy
• Enhanced catheter design to improve tracking, pushability and flexibility during deployment

Key Resources

• PLATINUM Diversity Study
• Directions for Use
• Indications, Safety, and Warnings

Ordering information (MONORAIL) — table rows shown as lines
Header: (mm) | STENT LENGTH (mm) | 8 | 12 | 16 | 20
Row: 2.25 | H7493952808220 | H7493952812220 | H7493952816220 | H7493952820220
Row: 2.5 | H7493952808250 | H7493952812250 | H7493952816250 | H7493952820250
Row: 2.75 | H7493952808270 | H7493952812270 | H7493952816270 | H7493952820270
Row: 3 | H7493952808300 | H7493952812300 | H7493952816300 | H7493952820300
Row: 3.5 | H7493952808350 | H7493952812350 | H7493952816350 | H7493952820350
Row: 4 | H7493952808400 | H7493952812400 | H7493952816400 | H7493952820400

Ordering information — additional lengths
Header: (mm) | STENT LENGTH (mm) | 24 | 28 | 32 | 38
Row: 2.25 | H7493952824220 | H7493952828220 | H7493952832220 | N/A
Row: 2.5 | H7493952824250 | H7493952828250 | H7493952832250 | H7493952838250
Row: 2.75 | H7493952824270 | H7493952828270 | H7493952832270 | H7493952838270
Row: 3 | H7493952824300 | H7493952828300 | H7493952832300 | H7493952838300
Row: 3.5 | H7493952824350 | H7493952828350 | H7493952832350 | H7493952838350
Row: 4 | H7493952824400 | H7493952828400 | H7493952832400 | H7493952838400

Clinical information (summary)
PLATINUM Workhorse Trial: Objective — evaluate safety and effectiveness of the Promus PtCr EES Coronary Stent System in patients with up to two de novo lesions ≤ 24 mm and vessel diameters ≥ 2.50 mm to ≤ 4.25 mm versus Xience CoCr EES. Study design — prospective, randomized, controlled, non‑inferiority, multicenter; 5‑year results reported with numerically lower event rates referenced.

Economic value
Unique Platinum Chromium (PtCr) stent alloy may support reduced device usage, shorter procedure times and lower radiation exposure.

Tools and Resources (examples)

• Latex Information: Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System (PDF)
• Metal Composition: Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System (PDF)
• MRI Safety: Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System (PDF)

Technical specifications

• Commercial name: Promus PREMIER™
• Manufacturer / Brand: Boston Scientific
• Stent alloy: Platinum Chromium (PtCr)
• Drug eluted: Everolimus
• Polymer: PVDF‑HFP
• Stent architecture: Customized PtCr stent architecture (first customized Platinum Chromium architecture)
• Catheter: Enhanced catheter design for improved tracking, pushability and flexibility
• Available nominal diameters: 2.25 mm, 2.50 mm, 2.75 mm, 3.00 mm, 3.50 mm, 4.00 mm
• Available stent lengths: 8, 12, 16, 20, 24, 28, 32, 38 mm (length availability varies by diameter — see ordering codes in ordering information)
• Intended use: Coronary stent system (drug‑eluting) for percutaneous coronary intervention
• C-code for outpatient reporting referenced: C1874 (Stent, coated/covered with delivery system)
• MRI safety and composition information available in product PDFs